Product Description
Neuromodulation device are machines that acts directly upon nerves. It is the alteration—or modulation—of nerve activity by delivering electrical or pharmaceutical agents directly to a target area.
The Neuromodulation Devices market revenue was xx Million USD in 2019, grew to xx Million USD in 2023, and will reach xx Million USD in 2031, with a CAGR of xx during 2024-2031.
Considering the influence of COVID-19 on the global Neuromodulation Devices market, this report analyzed the impact from both global and regional perspectives. From production end to consumption end in regions such as North America, Europe, China, and Japan, the report put emphasis on analysis of market under COVID-19 and corresponding response policy in different regions.
This report also analyzes the strategies for different companies to deal with the impact of COVID-19 in detail to seek a path to recovery.
Under COVID-19 Outbreak, how the Neuromodulation Devices Industry will develop is also analyzed in detail in Chapter 1.8 of this report.
Major Players in Neuromodulation Devices market are:
Cyberonics
Neuronetics
Medtronic
Synapse Biomedical
Neurosigma
BioControl Medical
Neuropace
Boston Scientific Corporation
St.Jude Medical
Nevro
Most important types of Neuromodulation Devices products covered in this report are:
Deep Brain Stimulation (DBS) Systems
Spinal Cord Stimulator (SCS) Systems
Diaphragm Pacing System (DPS)
Respiratory Electrical Stimulation (RES)
Vagus Nerve Stimulation (VNS)
Gastric Electrical Stimulation (GES)
Transcranial Magnetic Stimulation (TMS)
Transcutaneous Electrical Nerve Stimulation (TENS)
Most widely used downstream fields of Neuromodulation Devices market covered in this report are:
Chronic Pain
Parkinson's Disease
Urinary Fecal Incontinence
Refractory Epilepsy
Essential Tremor
Dystonia
Gastroparesis
Treatment-Resistant Depression (TRD)
Obsessive Compulsive Disorder (OCD)
Other Applications
Major Regions or countries covered in this report:
North America
Europe
China
Japan
Middle East and Africa
South America
India
South Korea
Southeast Asia
Others
In Chapter 3.4, the report provides analysis of the reasons behind price fluctuations.
In chapters 5, 6, and 7, the impact of COVID-19 on the different regions in both production and consumption end and SWOT analysis are pointed out.
In Chapters 8, the report presents company's recent development and strategies to deal with the impact of COVID-19.